Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression.

Kim J, Park S, Kang HM, Ahn CW, Kwon HC, Song JH, Lee YJ, Lee KH, Yang H, Baek SY, Yoo SH, Kim SH, Kim H.

Cell Transplant. 2012;21(10):2131-47. doi: 10.3727/096368912X636803. Epub 2012 Apr 2.

PMID:
22490341
2.

Generating β-cells in vitro: progress towards a Holy Grail.

Fryer BH, Rezania A, Zimmerman MC.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):112-7. doi: 10.1097/MED.0b013e32835edb4c. Review.

PMID:
23426161
3.

Human umbilical cord blood as an emerging stem cell therapy for diabetes mellitus.

Reddi AS, Kuppasani K, Ende N.

Curr Stem Cell Res Ther. 2010 Dec;5(4):356-61. Review.

PMID:
20528762
4.

Hands-on experiments on glycemia regulation and type 1 diabetes.

Mingueneau M, Chaix A, Scotti N, Chaix J, Reynders A, Hammond C, Thimonier J.

Adv Physiol Educ. 2015 Sep;39(3):232-9. doi: 10.1152/advan.00047.2015. Review.

5.

The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus.

Grapensparr L, Olerud J, Vasylovska S, Carlsson PO.

Regen Med. 2011 Sep;6(5):599-605. doi: 10.2217/rme.11.45. Review.

PMID:
21916595
6.

Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.

Hashemian SJ, Kouhnavard M, Nasli-Esfahani E.

J Diabetes Res. 2015;2015:675103. doi: 10.1155/2015/675103. Epub 2015 Oct 20. Review.

7.

Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.

Graham ML, Schuurman HJ.

Eur J Pharmacol. 2015 Jul 15;759:221-30. doi: 10.1016/j.ejphar.2015.02.054. Epub 2015 Mar 24. Review.

PMID:
25814249
8.

Humanized mice for the study of type 1 diabetes and beta cell function.

King M, Pearson T, Rossini AA, Shultz LD, Greiner DL.

Ann N Y Acad Sci. 2008 Dec;1150:46-53. doi: 10.1196/annals.1447.009. Review.

9.

Metabolic and cardiovascular effects of beta cell replacement in type 1 diabetes.

Marchetti P, Occhipinti M, Rondinini L, Mariotti R, Amorese G, Barsotti M, Vistoli F, Boggi U.

Intern Emerg Med. 2013 Apr;8 Suppl 1:S55-6. doi: 10.1007/s11739-013-0912-3. Review.

PMID:
23471700
10.

Mesenchymal stromal cells to halt the progression of type 1 diabetes?

Carlsson PO, Korsgren O, Le Blanc K.

Curr Diab Rep. 2015 Jul;15(7):46. doi: 10.1007/s11892-015-0616-3. Review.

PMID:
26003192
11.

Tissue engineering approaches to cell-based type 1 diabetes therapy.

Amer LD, Mahoney MJ, Bryant SJ.

Tissue Eng Part B Rev. 2014 Oct;20(5):455-67. doi: 10.1089/ten.TEB.2013.0462. Epub 2014 Apr 22. Review.

12.

[The toxic action of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes].

Kudriashov BA.

Izv Akad Nauk Ser Biol. 1993 Sep-Oct;(5):694-702. Review. Russian.

PMID:
8220079

Supplemental Content

Support Center